Anish Shah
Clinical Cardiac Electrophysiology · Salt Lake City, UTNPI 1437504131
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (59.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Abbott at 39.7% of the total.
Across 157 payments — averaging $272.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$17K
- Boston Scientific$14K
- Medtronic$5K
- Biotronik Inc.$3K
- Medical Device Business Services, Inc.$1K
- Novartis$311
- plus $1K from 13 others
What the payments were for
- Grants$25,31159%
- Travel & lodging$9,86423%
- Food & beverage$6,33615%
- Education$1,1973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $16,934 |
| Boston Scientific | 13 | $14,473 |
| Medtronic | 50 | $5,069 |
| Biotronik Inc. | 18 | $3,336 |
| Medical Device Business Services, Inc. | 10 | $1,485 |
| Novartis | 14 | $311 |
| Cardiovascular Systems Inc. | 4 | $264 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $249 |
| Cvrx, Inc. | 2 | $202 |
| Sanofi-aventis U.S. LLC | 1 | $118 |
| Actelion Pharmaceuticals US, Inc. | 2 | $70 |
| Abiomed | 1 | $55 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Pfizer | 1 | $23 |
| Amgen | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Biosense Webster, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$5,000
- TACTICATH$3,031
- ASSURITY$3,031
- ENSITE$3,022
- Rivacor$2,347
- Edora$2,347
- Acticor$2,347
- Farapulse$1,832
- Solia$1,627
- BioMonitor$1,627
- Carto 3$1,220
- Sentus$720
- Plexa$720
- Micra$651
- ENSITE PRECISION$420
- Diamondback Coronary$238
- AURORA EV-ICD MRI SURESCAN$163
- Barostim Neo System$142
- Diamondback Peripheral$131
- SelectSecure$117
How this compares
$42,707 in reported general payments places this provider in the 60th percentile of 29 clinical cardiac electrophysiology providers in Utah.
See all clinical cardiac electrophysiology providers in Utah →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 12 | $79 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Salt Lake City
- Ravi RanjanSalt Lake City$345K
- John DaySalt Lake City$313K
- Roger FreedmanSalt Lake City$177K
- Nischala NannapaneniSalt Lake City$57K
- Helge LehmannSalt Lake City$49K
- Richard SheltonSalt Lake City$47K
- Qussay MarashlySalt Lake City$34K
- Michael CrawfordSalt Lake City$30K
- Jared MillerSalt Lake City$8K
- Travis WallSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.